Skip to main content
. 2022 Feb 16;40(8):1180–1189. doi: 10.1016/j.vaccine.2021.11.061

Table 3.

Hazard ratios (95% confidence interval) for BNT162b2 effectiveness against PCR-confirmed COVID-19 infection in health care workers, relative to unvaccinated.

Unadjusted*
Adjusted**
Dose Week Person-years Events HR 95% CI HR 95% CI
Unvaccinated 12,748 4,680 1.00 1.00
First 0–2 4,028 1,080 0.94 (0.88, 1.01) 0.97 (0.90 to 1.04)
3–6 4,982 310 0.47 (0.41, 0.53) 0.48 (0.42 to 0.55)
7+ 2,123 140 0.60 (0.49, 0.74) 0.61 (0.50 to 0.76)
Second 0–1 2,711 60 0.31 (0.23, 0.42) 0.33 (0.24 to 0.44)
2–5 5,372 50 0.13 (0.09, 0.20) 0.14 (0.09 to 0.21)
6–13 10,414 230 0.21 (0.16, 0.28) 0.23 (0.17 to 0.31)
14–17 4,849 180 0.36 (0.28, 0.46) 0.40 (0.31 to 0.52)
18–21 4,554 360 0.38 (0.32, 0.45) 0.43 (0.36 to 0.50)
22–25 4,341 670 0.42 (0.37, 0.48) 0.47 (0.41 to 0.53)
26+ 4,997 1,570 0.48 (0.43, 0.54) 0.55 (0.49 to 0.61)
*

Only stratification by categories of prior number of PCR tests.

**

Main effects included staff group, sex, age, ethnicity, SES, urban/rural classification, QCovid co-morbidity score, previous number of hospitalisations, GP attendances and prescriptions over the last five years, with stratification by 'prior PCR test history'.

For disclosure purposes, number of events have been round to nearest 10.